Literature DB >> 12837993

Treatment of drug addiction in traumatised refugees. A case report.

Michael Brune1, Christian Haasen, Oktay Yagdiran, Enrique Bustos.   

Abstract

The comorbidity of post-traumatic stress disorder (PTSD) and drug addiction is quite often overlooked in refugees. However, the simultaneous treatment of both disorders is of elemental importance for a positive outcome in addicted and traumatised refugees. Furthermore, mutual misinterpretations of habits, behaviours and reactions through negligence of the distinct sociocultural context of patient and clinician often leads to unfavourable developments. These observations are exemplified in this case report. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2003        PMID: 12837993     DOI: 10.1159/000070985

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  5 in total

1.  The Conflict in East Ukraine: A Growing Need for Addiction Research and Substance Use Intervention for Vulnerable Populations.

Authors:  Sonny S Patel; Oleksandr Zvinchuk; Timothy B Erickson
Journal:  Forensic Sci Addict Res       Date:  2020-01-21

Review 2.  Epidemiology of Substance Use among Forced Migrants: A Global Systematic Review.

Authors:  Danielle Horyniak; Jason S Melo; Risa M Farrell; Victoria D Ojeda; Steffanie A Strathdee
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

Review 3.  Assessing the Risk of HIV and Hepatitis C among Internally Displaced Persons in Georgia.

Authors:  Joshua Elbaz
Journal:  Ann Glob Health       Date:  2020-06-24       Impact factor: 2.462

4.  Alcohol use among Congolese Babembe male refugees in Tarrant County: A qualitative study.

Authors:  Elvis Longanga Diese; Amy Raines-Milenkov; Martha Felini; Idara Akpan; Arbaz Hussain; Eva Baker
Journal:  PLoS One       Date:  2022-08-03       Impact factor: 3.752

5.  Multimorbidity in adult asylum seekers: a first overview.

Authors:  Carmen A Pfortmueller; Manuela Stotz; Gregor Lindner; Thomas Müller; Nicolas Rodondi; Aristomenis K Exadaktylos
Journal:  PLoS One       Date:  2013-12-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.